This page includes the latest FDA filings for United Therapeutics Corp. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | UTHR | DUNS 965460025 |
Device Company | Device | Date |
---|---|---|
United Therapeutics Corporation | Prescription Medication | 2024-11-09 |
United Therapeutics Corporation | Prescription Medication | 2024-09-20 |
United Therapeutics Corporation | Prescription Medication | 2024-08-17 |
United Therapeutics Corp. | Prescription Medication | 2024-05-02 |
United Therapeutics Corporation | Prescription Medication | 2024-02-01 |
United Therapeutics Corp. | Prescription Medication | 2023-12-20 |
United Therapeutics Corporation | Prescription Medication | 2023-12-16 |
United Therapeutics Corp. | Prescription Medication | 2023-12-16 |
United Therapeutics Corporation | Prescription Medication | 2023-12-16 |
United Therapeutics Corporation | Prescription Medication | 2023-10-12 |
United Therapeutics Corp. | Prescription Medication | 2023-08-11 |
United Therapeutics Corporation, Eli Lilly and Company | Prescription Medication | 2023-07-21 |
United Therapeutics Corp. | Prescription Medication | 2023-07-20 |
United Therapeutics Corporation | Prescription Medication | 2023-07-11 |
United Therapeutics Corporation | Prescription Medication | 2023-03-18 |
United Therapeutics Corp. | Prescription Medication | 2023-02-25 |
United Therapeutics Corporation | Tyvaso | 2023-02-13 |
United Therapeutics Corporation | Prescription Medication | 2023-01-21 |
United Therapeutics Corporation, Eli Lilly and Company | Prescription Medication | 2022-07-13 |
United Therapeutics Corporation | Prescription Medication | 2022-05-28 |
United Therapeutics Corporation | Prescription Medication | 2022-05-25 |
United Therapeutics Corporation | Tyvaso DPI | 2022-05-23 |
United Therapeutics Corporation | Tyvaso DPI | 2022-05-23 |
United Therapeutics Corporation | Tyvaso DPI | 2022-05-23 |
United Therapeutics Corporation | Tyvaso DPI | 2022-05-23 |
United Therapeutics Corporation | Tyvaso DPI | 2022-05-23 |
United Therapeutics Corporation | Tyvaso DPI | 2022-05-23 |
United Therapeutics Corporation | Tyvaso DPI | 2022-05-23 |
United Therapeutics Corporation | Tyvaso DPI | 2022-05-23 |
United Therapeutics Corporation | Tyvaso DPI | 2022-05-23 |
United Therapeutics Corporation | Tyvaso DPI | 2022-05-23 |
United Therapeutics Corporation | Tyvaso DPI | 2022-05-23 |
United Therapeutics Corporation | Tyvaso DPI | 2022-05-23 |
United Therapeutics Corporation | Prescription Medication | 2022-04-06 |
United Therapeutics Corp. | Prescription Medication | 2022-03-04 |
United Therapeutics Corporation | Remodulin | 2022-01-25 |
United Therapeutics Corporation | Prescription Medication | 2022-01-25 |
United Therapeutics Corp. | Prescription Medication | 2022-01-07 |
United Therapeutics Corporation, Eli Lilly and Company | Prescription Medication | 2021-12-03 |
United Therapeutics Corp. | Prescription Medication | 2021-07-24 |
United Therapeutics Corporation | Prescription Medication | 2021-06-04 |
United Therapeutics Corporation | Prescription Medication | 2021-04-17 |
United Therapeutics Corporation | Prescription Medication | 2021-02-27 |
United Therapeutics Corporation | Remunity | 2021-02-19 |
United Therapeutics Corporation | Remunity DKPI-11038-001 | 2021-02-19 |
United Therapeutics Corporation | Remunity | 2020-12-21 |
United Therapeutics Corporation | Remunity | 2020-12-21 |
United Therapeutics Corp. | Prescription Medication | 2020-11-14 |
United Therapeutics Corp. | Prescription Medication | 2020-11-03 |
United Therapeutics Corporation, Eli Lilly and Company | Prescription Medication | 2020-09-26 |
United Therapeutics Corp. | Prescription Medication | 2020-09-04 |
United Therapeutics Corporation, Eli Lilly and Company | Prescription Medication | 2020-06-20 |
United Therapeutics Corp. | Prescription Medication | 2020-02-19 |
United Therapeutics Corporation, Eli Lilly and Company | Prescription Medication | 2019-12-12 |
United Therapeutics Corp. | Prescription Medication | 2019-11-02 |
United Therapeutics Corporation | Prescription Medication | 2019-10-01 |
United Therapeutics Corporation | Prescription Medication | 2019-07-20 |
United Therapeutics Corp. | Prescription Medication | 2019-05-08 |
United Therapeutics Corporation, Eli Lilly and Company | Prescription Medication | 2017-08-04 |
United Therapeutics Corporation | Low Potassium Dextran Solution With Tris Diluent | 2016-02-19 |
United Therapeutics Corp. | Unituxin | 2015-03-10 |
United Therapeutics Corp. | Orenitram | 2013-12-20 |
United Therapeutics Corp. | Orenitram | 2013-12-20 |
United Therapeutics Corp. | Orenitram | 2013-12-20 |
United Therapeutics Corp. | Orenitram | 2013-12-20 |
United Therapeutics Corp. | Orenitram | 2013-12-20 |
United Therapeutics Corp. | TYVASO | 2009-08-14 |
United Therapeutics Corporation | ADCIRCA | 2009-05-22 |
United Therapeutics Corporation | Sterile Diluent For Remodulin | 2002-05-22 |
United Therapeutics Corporation | Remodulin | 2002-05-22 |
United Therapeutics Corporation | Remodulin | 2002-05-22 |
United Therapeutics Corporation | Remodulin | 2002-05-22 |
United Therapeutics Corporation | Remodulin | 2002-05-22 |
NCAGE Code | 3P7X8 | UNITED THERAPEUTICS CORPORATION |
CAGE Code | 3P7X8 | UNITED THERAPEUTICS CORPORATION |
S.A.M. Registration | 3P7X8 [965460025] | UNITED THERAPEUTICS CORPORATION |
SEC | 0001082554 | UNITED THERAPEUTICS Corp of DELAWARE |